Compare AMPH & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | TRIP |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2005 | 2011 |
| Metric | AMPH | TRIP |
|---|---|---|
| Price | $25.94 | $8.86 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 16 |
| Target Price | ★ $22.50 | $13.36 |
| AVG Volume (30 Days) | 486.8K | ★ 3.4M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 675.00 |
| EPS | ★ 0.81 | N/A |
| Revenue | $719,887,000.00 | ★ $1,556,000,000.00 |
| Revenue This Year | $3.87 | N/A |
| Revenue Next Year | $4.90 | $2.42 |
| P/E Ratio | $32.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.65 | $8.02 |
| 52 Week High | $29.52 | $17.82 |
| Indicator | AMPH | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 48.00 |
| Support Level | $25.23 | $8.41 |
| Resistance Level | $29.40 | $11.76 |
| Average True Range (ATR) | 0.91 | 0.30 |
| MACD | -0.10 | 0.12 |
| Stochastic Oscillator | 35.20 | 81.25 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.